Logo image of ALGM

ALLEGRO MICROSYSTEMS INC (ALGM) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:ALGM - US01749D1054 - Common Stock

30.64 USD
-0.89 (-2.82%)
Last: 1/7/2026, 8:15:41 PM
30.56 USD
-0.08 (-0.26%)
After Hours: 1/7/2026, 8:15:41 PM
Fundamental Rating

4

Taking everything into account, ALGM scores 4 out of 10 in our fundamental rating. ALGM was compared to 113 industry peers in the Semiconductors & Semiconductor Equipment industry. While ALGM seems to be doing ok healthwise, there are quite some concerns on its profitability. ALGM has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year ALGM was profitable.
In the past year ALGM had a positive cash flow from operations.
Of the past 5 years ALGM 4 years were profitable.
In the past 5 years ALGM always reported a positive cash flow from operatings.
ALGM Yearly Net Income VS EBIT VS OCF VS FCFALGM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M 200M

1.2 Ratios

ALGM's Return On Assets of -2.05% is on the low side compared to the rest of the industry. ALGM is outperformed by 60.18% of its industry peers.
ALGM's Return On Equity of -3.00% is in line compared to the rest of the industry. ALGM outperforms 43.36% of its industry peers.
Industry RankSector Rank
ROA -2.05%
ROE -3%
ROIC N/A
ROA(3y)6.9%
ROA(5y)7.3%
ROE(3y)8.35%
ROE(5y)8.88%
ROIC(3y)N/A
ROIC(5y)N/A
ALGM Yearly ROA, ROE, ROICALGM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10 15

1.3 Margins

The Gross Margin of ALGM (44.61%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of ALGM has grown nicely.
ALGM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.61%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.77%
GM growth 5Y1.99%
ALGM Yearly Profit, Operating, Gross MarginsALGM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 20 40

6

2. Health

2.1 Basic Checks

ALGM does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALGM has less shares outstanding
Compared to 5 years ago, ALGM has less shares outstanding
ALGM has a worse debt/assets ratio than last year.
ALGM Yearly Shares OutstandingALGM Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
ALGM Yearly Total Debt VS Total AssetsALGM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 8.75 indicates that ALGM is not in any danger for bankruptcy at the moment.
The Altman-Z score of ALGM (8.75) is better than 66.37% of its industry peers.
The Debt to FCF ratio of ALGM is 5.05, which is a neutral value as it means it would take ALGM, 5.05 years of fcf income to pay off all of its debts.
ALGM's Debt to FCF ratio of 5.05 is in line compared to the rest of the industry. ALGM outperforms 56.64% of its industry peers.
ALGM has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
ALGM has a Debt to Equity ratio (0.30) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 5.05
Altman-Z 8.75
ROIC/WACCN/A
WACC10.9%
ALGM Yearly LT Debt VS Equity VS FCFALGM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.3 Liquidity

ALGM has a Current Ratio of 3.89. This indicates that ALGM is financially healthy and has no problem in meeting its short term obligations.
ALGM's Current ratio of 3.89 is fine compared to the rest of the industry. ALGM outperforms 62.83% of its industry peers.
ALGM has a Quick Ratio of 2.48. This indicates that ALGM is financially healthy and has no problem in meeting its short term obligations.
ALGM has a Quick ratio of 2.48. This is in the better half of the industry: ALGM outperforms 60.18% of its industry peers.
Industry RankSector Rank
Current Ratio 3.89
Quick Ratio 2.48
ALGM Yearly Current Assets VS Current LiabilitesALGM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

5

3. Growth

3.1 Past

ALGM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -48.53%.
Measured over the past years, ALGM shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -32.49% on average per year.
Looking at the last year, ALGM shows a decrease in Revenue. The Revenue has decreased by -7.23% in the last year.
ALGM shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.21% yearly.
EPS 1Y (TTM)-48.53%
EPS 3Y-32.49%
EPS 5YN/A
EPS Q2Q%62.5%
Revenue 1Y (TTM)-7.23%
Revenue growth 3Y-1.93%
Revenue growth 5Y2.21%
Sales Q2Q%14.36%

3.2 Future

Based on estimates for the next years, ALGM will show a very strong growth in Earnings Per Share. The EPS will grow by 87.41% on average per year.
The Revenue is expected to grow by 19.38% on average over the next years. This is quite good.
EPS Next Y123.02%
EPS Next 2Y103.27%
EPS Next 3Y87.41%
EPS Next 5YN/A
Revenue Next Year20.87%
Revenue Next 2Y19.21%
Revenue Next 3Y19.38%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALGM Yearly Revenue VS EstimatesALGM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
ALGM Yearly EPS VS EstimatesALGM Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 87.54, the valuation of ALGM can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of ALGM is on the same level as its industry peers.
When comparing the Price/Earnings ratio of ALGM to the average of the S&P500 Index (26.92), we can say ALGM is valued expensively.
With a Price/Forward Earnings ratio of 30.90, ALGM can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, ALGM is valued a bit cheaper than the industry average as 61.95% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 23.57. ALGM is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 87.54
Fwd PE 30.9
ALGM Price Earnings VS Forward Price EarningsALGM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as ALGM.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALGM is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 99.65
EV/EBITDA 107.54
ALGM Per share dataALGM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

ALGM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ALGM's earnings are expected to grow with 87.41% in the coming years.
PEG (NY)0.71
PEG (5Y)N/A
EPS Next 2Y103.27%
EPS Next 3Y87.41%

0

5. Dividend

5.1 Amount

No dividends for ALGM!.
Industry RankSector Rank
Dividend Yield 0%

ALLEGRO MICROSYSTEMS INC

NASDAQ:ALGM (1/7/2026, 8:15:41 PM)

After market: 30.56 -0.08 (-0.26%)

30.64

-0.89 (-2.82%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)10-30 2025-10-30/bmo
Earnings (Next)01-28 2026-01-28/bmo
Inst Owners75.11%
Inst Owner Change0%
Ins Owners0.65%
Ins Owner Change0.1%
Market Cap5.67B
Revenue(TTM)788.39M
Net Income(TTM)-28.37M
Analysts83.33
Price Target39.19 (27.9%)
Short Float %7.3%
Short Ratio4.24
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.14%
Min EPS beat(2)3.13%
Max EPS beat(2)5.14%
EPS beat(4)4
Avg EPS beat(4)7.84%
Min EPS beat(4)3.13%
Max EPS beat(4)17.65%
EPS beat(8)8
Avg EPS beat(8)15.73%
EPS beat(12)12
Avg EPS beat(12)11.98%
EPS beat(16)16
Avg EPS beat(16)10.58%
Revenue beat(2)1
Avg Revenue beat(2)0.29%
Min Revenue beat(2)-0.26%
Max Revenue beat(2)0.84%
Revenue beat(4)2
Avg Revenue beat(4)0.38%
Min Revenue beat(4)-1.08%
Max Revenue beat(4)2.03%
Revenue beat(8)3
Avg Revenue beat(8)-0.39%
Revenue beat(12)3
Avg Revenue beat(12)-0.55%
Revenue beat(16)6
Avg Revenue beat(16)-0.1%
PT rev (1m)-0.43%
PT rev (3m)1.54%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.62%
EPS NY rev (1m)0%
EPS NY rev (3m)0.03%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.93%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.88%
Valuation
Industry RankSector Rank
PE 87.54
Fwd PE 30.9
P/S 7.19
P/FCF 99.65
P/OCF 60.25
P/B 6.01
P/tB 11.58
EV/EBITDA 107.54
EPS(TTM)0.35
EY1.14%
EPS(NY)0.99
Fwd EY3.24%
FCF(TTM)0.31
FCFY1%
OCF(TTM)0.51
OCFY1.66%
SpS4.26
BVpS5.1
TBVpS2.65
PEG (NY)0.71
PEG (5Y)N/A
Graham Number6.34
Profitability
Industry RankSector Rank
ROA -2.05%
ROE -3%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.61%
FCFM 7.22%
ROA(3y)6.9%
ROA(5y)7.3%
ROE(3y)8.35%
ROE(5y)8.88%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.77%
GM growth 5Y1.99%
F-Score3
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 5.05
Debt/EBITDA 5.12
Cap/Depr 57.39%
Cap/Sales 4.72%
Interest Coverage N/A
Cash Conversion 168.55%
Profit Quality N/A
Current Ratio 3.89
Quick Ratio 2.48
Altman-Z 8.75
F-Score3
WACC10.9%
ROIC/WACCN/A
Cap/Depr(3y)131.89%
Cap/Depr(5y)124.81%
Cap/Sales(3y)8.59%
Cap/Sales(5y)8.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-48.53%
EPS 3Y-32.49%
EPS 5YN/A
EPS Q2Q%62.5%
EPS Next Y123.02%
EPS Next 2Y103.27%
EPS Next 3Y87.41%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.23%
Revenue growth 3Y-1.93%
Revenue growth 5Y2.21%
Sales Q2Q%14.36%
Revenue Next Year20.87%
Revenue Next 2Y19.21%
Revenue Next 3Y19.38%
Revenue Next 5YN/A
EBIT growth 1Y-113.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year194.32%
EBIT Next 3Y86.13%
EBIT Next 5YN/A
FCF growth 1Y-26.17%
FCF growth 3Y-37.77%
FCF growth 5Y-10.31%
OCF growth 1Y-52.4%
OCF growth 3Y-26.53%
OCF growth 5Y-5.33%

ALLEGRO MICROSYSTEMS INC / ALGM FAQ

What is the ChartMill fundamental rating of ALLEGRO MICROSYSTEMS INC (ALGM) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALGM.


What is the valuation status for ALGM stock?

ChartMill assigns a valuation rating of 4 / 10 to ALLEGRO MICROSYSTEMS INC (ALGM). This can be considered as Fairly Valued.


What is the profitability of ALGM stock?

ALLEGRO MICROSYSTEMS INC (ALGM) has a profitability rating of 3 / 10.


What is the valuation of ALLEGRO MICROSYSTEMS INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ALLEGRO MICROSYSTEMS INC (ALGM) is 87.54 and the Price/Book (PB) ratio is 6.01.


How financially healthy is ALLEGRO MICROSYSTEMS INC?

The financial health rating of ALLEGRO MICROSYSTEMS INC (ALGM) is 6 / 10.